Citation Tools
PDFRegular and Young Investigator Award Abstracts
Combination Immunotherapies
879 Post-treatment neutrophil-to-lymphocyte ratio and gMDSCs as independent prognostic factors for treatment efficacy with monoclonal antibody NEO-201 and pembrolizumab
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 879 Post-treatment neutrophil-to-lymphocyte ratio and gMDSCs as independent prognostic factors for treatment efficacy with monoclonal antibody NEO-201 and pembrolizumab